Report Detail

Healthcare North America Onychomycosis (Tinea Unguium) Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2023

  • RnM2138979
  • |
  • 01 June, 2018
  • |
  • Global
  • |
  • 100 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Healthcare

Table of Contents

    1 Market Overview

    • 1.1 Onychomycosis (Tinea Unguium) Drug Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Oral
      • 1.2.2 External
    • 1.3 Market Analysis by Applications
      • 1.3.1 Age under 18
      • 1.3.2 Age 18-50
      • 1.3.3 Age above 50
    • 1.4 Market Analysis by Countries
      • 1.4.1 United States Status and Prospect (2013-2023)
      • 1.4.2 Mexico Status and Prospect (2013-2023)
      • 1.4.3 Canada Status and Prospect (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Johnson & Johnson
      • 2.1.1 Business Overview
      • 2.1.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
        • 2.1.2.1 Type 1
        • 2.1.2.2 Type 2
      • 2.1.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2 GSK
      • 2.2.1 Business Overview
      • 2.2.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
        • 2.2.2.1 Type 1
        • 2.2.2.2 Type 2
      • 2.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3 Novartis
      • 2.3.1 Business Overview
      • 2.3.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
        • 2.3.2.1 Type 1
        • 2.3.2.2 Type 2
      • 2.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4 Pfizer
      • 2.4.1 Business Overview
      • 2.4.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
        • 2.4.2.1 Type 1
        • 2.4.2.2 Type 2
      • 2.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5 Valeant Pharma
      • 2.5.1 Business Overview
      • 2.5.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
        • 2.5.2.1 Type 1
        • 2.5.2.2 Type 2
      • 2.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6 Kaken Pharmaceutical
      • 2.6.1 Business Overview
      • 2.6.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
        • 2.6.2.1 Type 1
        • 2.6.2.2 Type 2
      • 2.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7 Galderma
      • 2.7.1 Business Overview
      • 2.7.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
        • 2.7.2.1 Type 1
        • 2.7.2.2 Type 2
      • 2.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8 Xiuzheng Pharmaceutical
      • 2.8.1 Business Overview
      • 2.8.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
        • 2.8.2.1 Type 1
        • 2.8.2.2 Type 2
      • 2.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9 Letai
      • 2.9.1 Business Overview
      • 2.9.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
        • 2.9.2.1 Type 1
        • 2.9.2.2 Type 2
      • 2.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.10 Qilu Pharmaceutical
      • 2.10.1 Business Overview
      • 2.10.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
        • 2.10.2.1 Type 1
        • 2.10.2.2 Type 2
      • 2.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    3 North America Onychomycosis (Tinea Unguium) Drug Market Competition, by Manufacturer

    • 3.1 North America Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)
      • 3.1.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)
      • 3.1.2 North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer (2016-2017)
    • 3.2 North America Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)
      • 3.2.1 North America Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)
      • 3.2.2 North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer (2016-2017)
    • 3.3 North America Onychomycosis (Tinea Unguium) Drug Price by Manufacturers (2016-2017)
    • 3.4 Market Concentration Rate
      • 3.4.1 Top 3 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share (2016-2017)
      • 3.4.2 Top 5 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share (2016-2017)
    • 3.5 Market Competition Trend

    4 North America Onychomycosis (Tinea Unguium) Drug Market Analysis by Countries

    • 4.1 North America Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Countries (2013-2018)
      • 4.1.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Countries (2013-2018)
      • 4.1.2 North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2013-2018)
    • 4.2 North America Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Market Share by Countries (2013-2018)
      • 4.2.1 North America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
      • 4.2.2 North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)

    5 North America Market Segmentation Onychomycosis (Tinea Unguium) Drug by Type

    • 5.1 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2013-2018)
      • 5.1.1 North America Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)
      • 5.1.2 North America Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2013-2018)
    • 5.2 Type 1 Sales Growth Rate and Price
    • 5.2 Oral Sales Growth and Price
      • 5.2.1 North America Oral Sales Growth (2013-2018)
      • 5.2.2 North America Oral Price (2013-2018)
    • 5.3 External Sales Growth and Price
      • 5.3.1 North America External Sales Growth (2013-2018)
      • 5.3.2 North America External Price (2013-2018)

    6 North America Market Segmentation Onychomycosis (Tinea Unguium) Drug by Application

    • 6.1 North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)
    • 6.2 Age under 18 Sales Growth (2013-2018)
    • 6.3 Age 18-50 Sales Growth (2013-2018)
    • 6.4 Age above 50 Sales Growth (2013-2018)

    7 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

    • 7.1 United States Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)
    • 7.2 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type
      • 7.2.1 United States Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)
      • 7.2.2 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)
    • 7.3 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2013-2018)
      • 7.3.1 United States Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)
      • 7.3.2 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)
    • 7.4 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)
      • 7.4.1 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)
      • 7.4.2 United States Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)
    • 7.5 United States Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

    8 Canada Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

    • 8.1 Canada Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)
    • 8.2 Canada Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)
      • 8.2.1 Canada Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)
      • 8.2.2 Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)
    • 8.3 Canada Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2013-2018)
      • 8.3.1 Canada Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)
      • 8.3.2 Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)
    • 8.4 Canada Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)
      • 8.4.1 Canada Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)
      • 8.4.2 Canada Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)
    • 8.5 Canada Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

    9 Mexico Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

    • 9.1 Mexico Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)
    • 9.2 Mexico Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)
      • 9.2.1 Mexico Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)
      • 9.2.2 Mexico Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)
    • 9.3 Mexico Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2013-2018)
      • 9.3.1 Mexico Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)
      • 9.3.2 Mexico Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)
    • 9.4 Mexico Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)
      • 9.4.1 Mexico Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)
      • 9.4.2 Mexico Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)
    • 9.5 Mexico Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

    10 Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)

    • 10.1 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2018-2023)
    • 10.2 Onychomycosis (Tinea Unguium) Drug Market Forecast by Countries (2018-2023)
      • 10.2.1 North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Countries (2018-2023)
      • 10.2.2 United States Onychomycosis (Tinea Unguium) Drug Forecast (2018-2023)
      • 10.2.3 Canada Onychomycosis (Tinea Unguium) Drug Forecast (2018-2023)
      • 10.2.4 Mexico Onychomycosis (Tinea Unguium) Drug Forecast (2018-2023)
    • 10.3 Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2018-2023)
      • 10.3.1 North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2018-2023)
      • 10.3.2 North America Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2018-2023)
    • 10.4 Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2018-2023)
      • 10.4.1 North America Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2018-2023)
      • 10.4.2 North America Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2018-2023)

    11 Onychomycosis (Tinea Unguium) Drug Manufacturing Cost Analysis

    • 11.1 Onychomycosis (Tinea Unguium) Drug Key Raw Materials Analysis
      • 11.1.1 Key Raw Materials
      • 11.1.2 Price Trend of Key Raw Materials
      • 11.1.3 Key Suppliers of Raw Materials
      • 11.1.4 Market Concentration Rate of Raw Materials
    • 11.2 Proportion of Manufacturing Cost Structure
      • 11.2.1 Raw Materials
      • 11.2.2 Labor Cost
      • 11.2.3 Manufacturing Expenses
    • 11.3 Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug

    12 Industrial Chain, Sourcing Strategy and Downstream Buyers

    • 12.1 Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
    • 12.2 Upstream Raw Materials Sourcing
    • 12.3 Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Manufacturers in 2017
    • 12.4 Downstream Buyers

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      "Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
      Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease"

      Scope of the Report:
      This report focuses on the Onychomycosis (Tinea Unguium) Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
      Market Segment by Manufacturers, this report covers
      Johnson & Johnson
      GSK
      Novartis
      Pfizer
      Valeant Pharma
      Kaken Pharmaceutical
      Galderma
      Xiuzheng Pharmaceutical
      Letai
      Qilu Pharmaceutical

      Market Segment by Countries, covering
      Oral
      External

      Market Segment by Type, covers
      Age under 18
      Age 18-50
      Age above 50

      Market Segment by Applications, can be divided into
      Age under 18
      Age 18-50
      Age above 50

      There are 15 Chapters to deeply display the North America Onychomycosis (Tinea Unguium) Drug market.

      Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the manufacturers of Onychomycosis (Tinea Unguium) Drug , with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

      Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Onychomycosis (Tinea Unguium) Drug , for each country, from 2013 to 2018;

      Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

      Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

      Chapter 10, Onychomycosis (Tinea Unguium) Drug market forecast, by countries, type and application, with sales, price and revenue, from 2018 to 2023;

      Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

      Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

      Chapter 13, to describe sales channel, distributors, traders, dealers etc.

      Chapter 14 and 15, to describe Onychomycosis (Tinea Unguium) Drug Research Findings and Conclusion, Appendix, methodology and data source


      Summary:
      Get latest Market Research Reports on Onychomycosis (Tinea Unguium) Drug . Industry analysis & Market Report on Onychomycosis (Tinea Unguium) Drug is a syndicated market report, published as North America Onychomycosis (Tinea Unguium) Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Onychomycosis (Tinea Unguium) Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,480.00
      $8,960.00
      3,287.38
      6,574.77
      3,692.79
      7,385.58
      465,301.76
      930,603.52
      327,674.82
      655,349.63
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report